Pacific Biosciences
PACB
#6928
Rank
ยฃ0.53 B
Marketcap
ยฃ1.74
Share price
-15.44%
Change (1 day)
53.07%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of June 2026 : ยฃ0.17 Billion

According to Pacific Biosciences 's latest financial reports the company has ยฃ0.17 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ0.20 B-33.21%
2024-12-31ยฃ0.31 B-37.31%
2023-12-31ยฃ0.49 B-22.36%
2022-12-31ยฃ0.63 B-17.49%
2021-12-31ยฃ0.77 B230.8%
2020-12-31ยฃ0.23 B524.67%
2019-12-31ยฃ37.44 M-53.56%
2018-12-31ยฃ80.63 M73.33%
2017-12-31ยฃ46.51 M-20.25%
2016-12-31ยฃ58.33 M5.08%
2015-12-31ยฃ55.51 M-14.72%
2014-12-31ยฃ65.09 M-4.58%
2013-12-31ยฃ68.21 M9.63%
2012-12-31ยฃ62.22 M-45.49%
2011-12-31ยฃ0.11 B-37.88%
2010-12-31ยฃ0.18 B220.66%
2009-12-31ยฃ57.3 M-20.8%
2008-12-31ยฃ72.35 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ3.06 B 1,615.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ7.05 B 3,845.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.87 B 387.60%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
ยฃ1.85 B 939.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
ยฃ73.34 M-59.01%๐Ÿ‡บ๐Ÿ‡ธ USA